- AU$13.27m
- AU$11.98m
- AU$0.51m
Brief: Renerve And Rmit Awarded A$499K Grant
Brief: ReNerve Posts Full-Year Loss Attributable Of A$5.6 Million
Brief: ReNerve Says Nervalign Nerve Cuff Receives CDSCO Marketing Approval In India
Australia's ReNerve rises on securing up to A$5 million funding facility
Brief: ReNerve Secures Up To A$5 Million Funding Facility
Brief: ReNerve Receives Marketing Approval For Nervalign Nerve Cuff In Indonesia
Brief: Renerve Appoints J4 As Second Empliq Manufacturing Partner
Brief: Renerve Appoints UG Medical As Distribution Partner For Malaysian Market
Brief: Renerve Says New Distribution Agreement For Broader Hong Kong Market
Brief: ReNerve Says Quarterly Sales Rose By 80% Compared To Corresponding Quarter
Brief: ReNerve Announces NervAlign Nerve Cuff Approval In Malaysia
Australia's ReNerve rises on Malaysian approval for its NervAlign product
Brief: Renerve Says Broader Approval Received In Hong Kong For Nerve Cuff
Brief: Renerve Announces Board Changes
Australia's ReNerve drops on discounted placement
Brief: ReNerve To Raise A$3.2M Via Placement
Brief: Renerve Seeks Trading Halt
ReNerve eyes best session on record after US nerve repair tech approval
Australia's ReNerve at four-month high on medical product launch